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Edited by Stuart FergusonAbstract In an attempt to endow Cyt1Ca with Cyt1Aa-like
antibacterial activity, both derived from Bacillus thuringiensis
subsp. israelensis, two amino acids were replaced, E117V and
N125A, so as to raise the hydrophobicity of the corresponding
region, considered to be the membrane-active motif. The clones
obtained included multiple repeats of VIEVLKSLLGIALA, cor-
responding to head-to-tail polymerization of the primer, trans-
lated in frame with Cyt1Ca. These versions of Cyt1Ca caused
instant arrest in biomass growth and decreased viability upon
expression in Escherichia coli. Multiple insertions of the non-mu-
tated motif VIEELKSLLGINLA into the polypeptide were also
lethal. To expose toxicity of the latter motif in the original
Cyt1Ca, cyt1Ca was appropriately truncated.
 2007 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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repeated motif; Microgene polymerization reaction1. Introduction
The major component of the parasporal crystal of Bacillus
thuringiensis subsp. israelensis, a gram-positive bacterium
pathogenic for Dipteran species [1], is Cyt1Aa [2,3], which
eﬀectively lyses a broad range of cells and so belongs to the
cytolytic family of B. thuringiensis toxins [4]. Despite low larvi-
cidal activity by itself, Cyt1Aa contributes to the overall
toxicity of B. thuringiensis by acting synergistically with the
receptor-speciﬁc Cry toxins [5,6], and hence suppresses resis-
tance to them in target insects [7–9]. Moreover, Cyt1Aa exerts
strong toxicity on bacteria when produced internally [10–13] or
applied externally [14].
A new coding sequence cyt1Ca has recently been detected on
pBtoxis, the large toxin-coding plasmid of B. thuringiensis
subsp. israelensis [15], with predicted product of a two-domain
fusion protein. The N-terminal part is 52% identical to Cyt1Aa
and the C-terminal part is similar to the receptor binding do-
main of ricin-B lectin type, found in several toxins: ricin, Clos-
tridium botulinum neurotoxin and the mosquito-larvicidal
Mtx1 from B. sphaericus [15]. Despite its high similarity to Cy-
t1Aa, neither full-length Cyt1Ca nor its Cyt1A-like truncated
versions were bactericidal or synergistic to Cry4Aa against*Corresponding author. Fax: +972 8 6278 951.
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doi:10.1016/j.febslet.2007.03.064Aedes aegypti larvae [16]. No function has yet been assigned
for it despite cyt1Ca transcription in B. thuringiensis [17].
Consecutive site-directed replacements of Q149K, Q159E,
A185C and G235D according to Cyt1Aa revealed some Cy-
t1Ca variants with antibacterial but not larvicidal activities
[18]. The acquired toxicities were attributed to stronger electro-
static interactions of the modiﬁed Cyt1Ca versions to lipid
head groups in the bacterial inner membrane. The much lower
antibacterial activities than those of Cyt1Aa are likely due to
poor interactions of the mutated versions with the hydropho-
bic lipid core of the membrane. Cyt1Aa indeed includes one re-
gion of increased hydrophobicity (Fig. 1) that overlays on one
of two a-helices that were proposed to play a signiﬁcant role in
the initial binding of the toxin to the membrane [19]. The
hydrophobicity of a helix C and its adjacent regions of the
Cyt1A-like domain of Cyt1Ca are still lower than that of
Cyt1Aa (Fig. 1A). To raise it to a value similar to that of
Cyt1Aa, E117 was replaced by V and N125 by A (Figs. 1B,
2A). The results uncover some cryptic bacteriocidity of Cyt1Ca.2. Materials and methods
2.1. Bacterial strains and plasmids
All plasmids used in this study (Table 1) were introduced into Esch-
erichia coli strain XL-Blue MRF’.
2.2. Site-directed mutagenesis
The method used was based on Stratagene’s QuickChange Site-Di-
rected Mutagenesis Kit. The recombinant plasmid pUH-cyCtrC (Table
1) was used as template for the double substitution E117V-N125A and
BspHI site elimination, together with the primers Pr-E117V-N125A
and Pr-cyCDBspH (Table 2) and their respective complements. Gener-
ation of each mutation was conﬁrmed by examining the corresponding
restriction enzymes (Table 2), and sequencing.
2.3. Inserting products of microgene polymerisation reaction (MPR)
[20] into cyt1Ca
MPR products were generated from primer Pr-MPR (Table 2) and
its complement, which are related to the a-helix C of Cyt1Aa. A 50-
ll reaction mixture contained 16 pmol of each of the primers, 4 lg
of pUH-cyCtrC and 25 nmol of each of the dNTPs, in 10 mM
KCl,10 mM (NH4)2SO4, 20 mM Tris–HCl (pH 8.8), 8 mM MgSO4,
0.1% Triton X-100, and 2 unit of Vent DNA polymerase (MBI Fer-
mentas). The reaction started by pre-heating at 94.0 C for 10 min,
was followed by 65 cycles at 69.4 C for 1 min and 72.2 C for 1 min
(these cycle conditions, lacking high temperature denaturation stage,
were used to generate multiply repeated DNA from Pr-MPR homo-
duplex without vector ampliﬁcation), and ﬁnalized by 16 cycles at
94.0 C for 30 s 50.0 C for 1 min and 72.0 C for 3 min (these cycles
include high temperature vector denaturation stage for inserting the
multiply repeated homo-duplex products into a speciﬁc site in the
frame of cyt1Ca). The PCR product was treated by DpnI overnightblished by Elsevier B.V. All rights reserved.
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Fig. 1. Hydropathy score analyses of Cyt1Aa (black lines) and Cyt1Ca
(grey lines), the latter truncated at N244, original version (A) and with
E117V and N125A replacements (B). The arrow points to the position
of the a helix C of Cyt1Aa.
Table 1
PUHE-24S-based plasmids encoding the described products
Plasmid (amplicon) name Description of product
pUHE-24S Empty vector
pRM4-C (cyt1Ca) Cyt1Aa
pUH-cyCtrC (cyCtrC) Cyt1Ca truncated at N244
(CyCtrC) (Fig. 2)
pUH-cyCtrCDBspH (cyCtrCDBspH) pUH-cyCtrC Quick-change
to eliminate BspHI site
pUH-cy-aCtr (cy-aCtr) CyCtrC truncated at Y146
at C terminal (Fig. 2)
pUH-cy-aNtr (cy-aNtr) CyCtrC truncated at M110
at N terminal (Fig. 2)
pUH-cyCEVNA (cyCEVNA) CyCtrC with amino acid
changes E117V N125A (Fi
pUH-cyCEVNA-2Rep (cyCEVNA-2Rep) CyCtrC containing 2 repea
primer Pr-E117V-N125A (
pUH-cyCEVNA-2RepT (cyCEVNA-2RepT) CyCtrC containing 2 repea
primer Pr-E117V-N125A w
termination (Fig. 3C)
pUH-cyCEVNA-6Rep (cyCEVNA-6Rep) CyCtrC containing 6 repea
primer Pr-E117V-N125A (
pUH-cy-2Rep (cy-2Rep) CyCtrC containing 2 repea
primer Pr-MPR (Fig. 6B)
pUH-cy-3RepT (cy-3RepT) CyCtrC containing 3 repea
primer Pr-MPR with termi
(Fig. 6A)
aSequences of the primers are shown in Table 2.
1776 M. Itsko, A. Zaritsky / FEBS Letters 581 (2007) 1775–1782and used to transform E. coli XL-Blue MRF’. Transformants were
grown on LB plates with 100 lg ampicilin ml1 and replicated onto
the same plates with 1 mM IPTG. Clones which were non-viable on
IPTG-containing plates were further studied.
2.4. Construction of plasmids with truncated versions of cyt1Ca
The primers Pr-pUH-Direct and Pr-cyC438C-Rev were employed to
obtain a 3 0 truncated cyt1Ca at position 438 (amplicon cy-aCtr coding
for Cyt1Ca truncated at Y146 (C-terminus)); Pr-cyC330N-Direct and
Pr-pUH-Rev were employed to obtain a double truncated cyt1Ca at
330 (5 0) and 732 (3 0) (amplicon cy-aNtr coding for Cyt1Ca truncated
at M110 (N-terminus) and N244 (C-terminus)) (Tables 1 and 2;
Fig. 2). These were PCR-ampliﬁed from pUH-cyCtrC and pUH-cyC-
trCDBspH as templates, respectively (Table 1) with Vent polymerase
(MBI Fermentas) in a DNA thermal cycler for 30-reaction cycle each
of 50 s at 94 C, 50 s at 50 C and 40 s at 72 C. The 599-bp amplicon
for cy-aCtr was digested with XhoI/XbaI (Table 2) and inserted into
the same sites of pUHE-24S to yield pUH-cy-aCtr. The 449-bp ampli-
con for cy-aNtr was digested with BsphI/XbaI (Table 2) and inserted
intoNcoI/XbaI-cut pUHE-24S to yield pUH-cy-aNtr.
2.5. Viable cell counts
Viability was determined by colony-forming ability (after 24 h incu-
bation at 37 C) on LB plates with 100 lg ampicillin ml1 following
appropriate dilutions.
2.6. Western blot analysis
E. coli cells were harvested by centrifugation 3–4 h after induction,
re-suspended in distilled water, and boiled (10 min) in sample treat-
ment buﬀer (62.5 mM Tris–Cl, pH 6.8, 2% SDS, 10% glycerol (v/v),
0.01% Bromophenol blue and 0.1 M DTT). Samples were analyzed
by SDS–PAGE [23]. Proteins were electro-transferred from the gel
onto nitrocellulose membranes and exposed to anti-Cyt1Ca antiserum
(kindly provided by Dr. Colin Berry of Cardiﬀ University, UK).
Protein A-alkaline phosphatase conjugate was the primary antibody
detector. Visualization of the antigen was achieved using Sigma
Fast-5-bromo-4-chloro-3-indolylphosphate/nitro blue tetrazolium.
2.7. Microscopy
Aliquots of growing cultures were ﬁxed by 0.25% formaldehyde for
morphology determinations of cells and inclusion bodies, whereas
unﬁxed aliquots were used for determination of bacterial membranePrimersa Ref.
[11]
[11]
[18]
d Pr-cyCDBspH and its complement This study
Pr-pUH-Direct and Pr-cyC438C-Rev This study
Pr-cyC330N-Direct and Pr-pUH-Rev This study
g. 2)
Pr-E117V-N125A and its complement This study
ts of
Fig. 3A)
Pr-E117V-N125A and its complement This study
ts of
ith
Pr-E117V-N125A and its complement This study
ts of
Fig. 3B)
Pr-E117V-N125A and its complement This study
ts of Pr-MPR and its complement This study
ts of
nation
Pr-MPR and its complement This study
Table 2
Sequences of the primers used (Table 1)
Primer Sequence (5 0–3 0)a Restriction enzyme
Pr-E117V-N125A GGTGATAGAAGTGCTTAAATCTTTATTAGGAATTGCTCTGGC VspI eliminated
Pr-cyCDBspH CGCAATTCAAGTTATGCAGCCATTGATCCATGAGAGTTTTCAACCC BspHI eliminated
Pr-pUH-Direct CCCTTTCGTCTTCACCTCGAGAAAATTTATCAAAAAG XhoI
Pr-cyC438C-Rev CCAAAAAAGCCATCTAGATTGCTGTTGTTAGTAGAGG XbaI
Pr-cyC330N-Direct CAAGTACAGTTCATGATAAATAAGGTGATAGAAGAG BsphI generated
Pr-pUH-Rev CGCGCGAGGCAGCTCTAGAGCACTTC XbaI
Pr-MPR GGTGATAGAAGAACTTAAATCTTTATTAGGAATTAACCTGGC VspI eliminated
aChanged nucleotides are indicated in bold type; restriction enzyme recognition sites are underlined.
M. Itsko, A. Zaritsky / FEBS Letters 581 (2007) 1775–1782 1777perforation. The samples were immobilized on object slides coated with
solidiﬁed 1% solution of agarose [25], containing 0.9%NaCl (ﬁxed sam-
ples) or LB broth and 0.5 lg ml1 Ethidium Bromide (unﬁxed samples).
Cells were visualized by phase-contrast or ﬂuorescence (unﬁxed samples
only) microscope (Nicon eclipse TE 2000-5; ﬂuorescence ﬁlter: excita-
tion at 540 and emission at 605 nm), equipped with Nicon sight
DS-U1 CCD camera and photographed using NIS-Elements Br 2.10
software.3. Results
The double mutant of the Cyt1A-like domain of Cyt1Ca,
containing E117V-N125A, was non-viable on IPTG-contain-
ing plates. A repeated motif, VIEVLKSLLGIALA, was found
in these clones in variable numbers (up to six), correspondingFig. 2. Sequence alignment of Cyt1Aa and the Cyt1A-like domain of Cyt1Ca
[24]. The amino acids replaced in this study are underlined and numbered. Ar
C- and N-termini (clones pUH-cy-aCtr and pUH-cy-aNtr) (black and grey,to head-to-tail tandem polymerization of the primer, some-
times accompanied by deletion of one or several nucleotides
at the junctions between the primer units (Fig. 3). The variants
thus produced encode a protein, either with an embedded re-
peated motif (Fig. 3A and B) or which exits frame at a certain
repeat (Fig. 3C). This phenomenon, known as microgene poly-
merization reaction (MPR), will brieﬂy be discussed below and
detailed elsewhere (manuscript in preparation). The corre-
sponding larger protein bands obtained by Western blot anal-
ysis with anti-Cyt1Ca antibodies (compare lanes 5 and 6 with
lane 4 in Fig. 4) are consistent with the presence of repeats in
the Cyt1Ca versions.
IPTG-induction of the repeats-including cyt1Ca variants
slowed (in pUH-cyCEVNA-2Rep) or completely arrested (in(clone pUH-cyCtrC) with the secondary structure elements in Cyt2Aa
rowheads point to Cyt1Ca truncations to expose a helix C and D at the
respectively).
Fig. 3. Examples of encoding nucleotides and the corresponding amino acids sequences of Cyt1Ca variants toxic to E. coli in pUH-cyCEVNA-2Rep
(A), pUH-cyCEVNA-6Rep (B) and pUH-cyCEVNA-2RepT (C). Dashes indicate deletions, and points indicate continued sequence as in Cyt1Ca C-
terminally truncated at N244. The repeated region is shown in grey.
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Fig. 4. Immunoblot analysis of mutated Cyt1Ca versions in clones
pUH-cyCEVNA-6Rep, pUH-cyCEVNA-2Rep and pUH-cyCEVNA
(lanes 4, 5 and 6, respectively). Lane 3, extract of a clone harboring
empty vector. Lane 2, puriﬁed full-length His-tagged Cyt1Ca [16].
Lane 1, molecular size marker. Arrowheads point to bands, suggested
for Cyt1Ca versions, contained in the corresponding clones.
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Fig. 5. Viable cell counts (A) and biomass (B) of E. coli clones,
induced (closed symbols) with IPTG at time 0 (vertical line) and un-
induced (open circles), harbouring either pUH-cyCEVNA (circles),
pUH-cyCEVNA-2Rep (squares), pUH-cyCEVNA-6Rep (diamonds),
pUH-cyCEVNA-2RepT (triangles), or pRM4-C (inverse triangles).
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Fig. 6. Amino acid sequences of Cyt1Ca versions toxic to E. coli produced in
deletions, and points indicate continued sequence as in Cyt1Ca C-terminally
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growth (Table 1; Fig. 5B), accompanied by immediate de-
creased viability (Fig. 5A). A most dramatic decrease in viabil-
ity after induction, approaching that of the clone expressing
cyt1Aa, was displayed by clone pUH-cyCEVNA-2RepT. The
toxicity revealed in the above clones may therefore be attrib-
uted to the motif repetition, either as such or with the mutated
version. This is conﬁrmed by the fact that induction of pUH-
cyCEVNA (containing the E117V-N125A double mutation
with no repeats) was not toxic to E. coli (Fig. 5).
To distinguish between these two possibilities, the repetitive
non-mutated motif VIEELKSLLGINLA was inserted into the
Cyt1A-like domain of Cyt1Ca as described in Section 2.3. All
selected clones that were non-viable on IPTG-containing
plates include head-to-tail primer repeats that are translated
with this repeated oligopeptide motif, either embedded in Cy-
t1Ca frame or terminated early by an occasional non-sense co-
don (Fig. 6). Two of these versions, pUH-cy-2Rep and pUH-
cy-3RepT (Table 1), respectively, were toxic to their E. coli
host, indicating a crucial role of the repetitive motif in the
lethal action (Fig. 7).
The observed lethality to E. coli of these Cyt1Ca derivatives
indicates that the motif of Cyt1Ca homologous to fragment of
a helix C and its downstream inter-helical loop of Cyt1Aa are
responsible. In order to expose the presumed hidden toxicity
attributed to this helix in the original, not active Cyt1A-like
domain of Cyt1Ca (clone pUH-cyCtrC (Table 1)), two trun-
cated versions were generated (Fig. 2), the considered motif
in one is situated near the N terminus of the protein whereas
in the second, it is situated near the C terminus. Indeed, induc-
tion of these truncated versions instantly arrested both bio-
mass growth and viability in a way similar to clones
containing the multiply repeated motifs described above
(Fig. 8).4. Discussion
Certain previously derived mutational changes endow the
Cyt1A-like domain of Cyt1Ca with antibacterial eﬀects [18].
These eﬀects were however weak compared with those of Cy-
t1Aa: no arrest in biomass growth was observed after induc-
tion of the mutated versions, viability decreased slightly at
best after a lag of 1 h, and cell divisions resumed after some
time. In this study, the cryptic cyt1Ca was further modiﬁed
aiming to reveal its potential function in B. thuringiensis subsp.
israelensis. The mutational manipulations were directed to the
sequence homologous to the a helix C and its downstream in-
ter-helical loop of Cyt1Aa (Fig. 1) because this sequence had
been proposed as the region important for Cyt1Aa activity
[19].the clones: pUH- cy-3RepT (A) and pUH-cy-2Rep (B). Dashes indicate
truncated at N244. The repeated regions are shown in grey.
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Fig. 7. Viable cell counts (A) and biomass (B) of E. coli clones,
induced (closed symbols) with IPTG at time 0 (vertical line) and un-
induced (open symbols), harbouring either pUH-cy-2Rep (circles) or
pUH-cy-3RepT (squares).
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Fig. 8. Viable cell counts (A) and biomass (B) of E. coli clones,
induced (closed symbols) with IPTG at time 0 (vertical line) and un-
induced (open symbols), harbouring pUH-cy-aCtr (squares), pUH-cy-
aNtr (triangles), pUH-cyCtrC (circles).
1780 M. Itsko, A. Zaritsky / FEBS Letters 581 (2007) 1775–1782Biomass growth was arrested immediately after induction of
all clones that produce Cyt1Ca variants terminated down-
stream a helix C-like motif (pUH-cy-3RepT, pUH-cyC-
EVNA-2RepT, pUH- cy-aCtr, pUH-cy-aNtr) and of one that
is not terminated but contains six repeats of the above motif
(pUH- cyCEVNA-6Rep) (Figs. 5, 7 and 8), indicating high tox-Fig. 9. Phase contrast (A–D) and ﬂuorescence micrographs of ethidium bro
pUH-cy-aCtr (B,F), pRM4-C (C,G), pUH-cyCEVNA-2RepT (D,H), after 2icity of these derivatives to the host cell. Very high toxicity of
pUH- cyCEVNA-2RepT (Fig. 5) may be attributed to proba-
ble membrane perforation by the corresponding protein deriv-
ative, similar to Cyt1Aa-producing clone [12], as can be
assayed by Ethidium Bromide staining (Fig. 9). The other
Cyt1Ca versions constructed here seem to not perforate themide-treated (E–H) E. coli cells harboring plasmids pUHE-24S (A,E),
h induction. Magniﬁcation bars, 5 lm.
M. Itsko, A. Zaritsky / FEBS Letters 581 (2007) 1775–1782 1781membrane (shown (Fig. 9) only for clone pUH- cy-aCtr) prob-
ably due to their milder eﬀect on the bacterial inner membrane.
As a consequence of blocking protein synthesis, these clones
are unable to accumulate the corresponding proteins in suﬃ-
cient amounts for good visualization by Western blot (data
shown (Fig. 4) only for pUH-cyCEVNA-6Rep).
Inducing pUH-cyCEVNA-2Rep (Fig. 5B) or pUH-cy-2Rep
(Fig. 7B) did not immediately arrest biomass growth. How-
ever, it was slowed down and accompanied with decreased via-
bility. Only these clones produced the corresponding proteins
aggregated into multiple inclusion bodies clearly seen after
induction (Fig. 10, top panels J and I, respectively). The inclu-Fig. 10. Top. Phase contrast micrographs of E. coli cells harboring
pUHE-24S (A,F), pUH-cyCtrC (B,G), pUH-cyCEVNA (C,H), pUH-
cy-2Rep (D,I) and pUH-cyCEVNA-2Rep (E,J) after 2 (A–E) and 6 (F–
J) hours of IPTG induction. Magniﬁcation bars, 5 lm. Bottom.
Immunoblot analysis of mutated Cyt1Ca versions produced in the
same clones: pUHE-24S (lane 1), pUH-cyCEVNA-2Rep (lane 2),
pUH-cyCEVNA (lane 3), pUH-cy-2Rep (lane 4), pUH-cyCtrC (lane
5), molecular size marker (lane 6). Arrowheads point to bands,
suggested for toxic derivatives of processed Cyt1Ca versions in the
corresponding clones.sion bodies seen on envelope of cells carrying pUH-cyCEVNA-
2Rep (Fig. 10, top panels E and J) support our contention that
the manipulated Cyt1Ca versions interact with the bacterial
membrane [18]. Biomass growth of pUH-cyCtrC (Fig. 8B)
and pUH-cyCEVNA (Fig. 5B) continued unimpeded and
was accompanied by generation of single inclusion body at
the late stage of induction (Fig. 10, top panels G and H,
respectively). The higher toxicities of pUH-cyCEVNA-2Rep
and pUH-cy-2Rep than those of pUH-cyCtrC and pUH-cyC-
EVNA may be explained by processing of the corresponding
proteins into their toxic derivatives in the former two clones.
This interpretation is consistent with the presence of low-
molecular weight products detected by Western Blot analysis
in pUH-cyCEVNA-2Rep and pUH-cy-2Rep, contrary to
pUH -cyCtrC and pUH-cyCEVNA (Fig. 10, bottom panel).
The amounts of these putatively toxic low-molecular weight
products exceeded those of the truncated products mentioned
in the preceding paragraph (hardly seen on the immunoblot)
(data not shown) so their deleterious eﬀect on the cells may
be more pronounced. This may explain the more signiﬁcant
drop in viability in pUH-cy-2Rep than of pUH-cy-3RepT
(Fig. 7A).
Diﬀerent extents of toxicity of Cyt1Ca derivatives to host
cells studied here may mean diﬀerent extents of interplay be-
tween two processes involving the produced polypeptide: inter-
action with the bacterial membrane, and competitive self
aggregation into inclusion body. Strong, stable interactions
with the membrane of the highly toxic Cyt1Ca derivatives
(clones pUH-cy-3RepT, pUH-cyCEVNA-2RepT, pUH-cyC-
EVNA-6Rep, pUH-cy-aCtr, pUH-cy-aNtr) may thus prevent
their self-aggregation, whereas in the non-toxic strains (clones
pUH-cyCtrC and pUH-cyCEVNA), they do not interact with
the membrane, and not being tolerated as soluble proteins in
the cytoplasm, they deposit around single aggregation nuclei
forming single inclusion bodies. In moderately toxic strains
(clones pUH-cyCEVNA-2Rep and pUH-cy-2Rep), protein–
membrane interactions of Cyt1Ca derivatives is presumably
weak, and hence their dynamic association/dissociation with/
from the membrane allows some protein aggregation in close
proximity to the membrane binding sites, the process which
generates multiple inclusion bodies spread near the cell enve-
lope.
Deriving repetitions of the non-mutated motif
VIEELKSLLGINLA in Cyt1Ca was not straightforward. A
special procedure was devised based on the head-to-tail primer
polymerization, which sheds some additional light on the
importance of this region to Cyt1Ca activity.
Head-to-tail primer polymerization, named microgene poly-
merization reaction (MPR), can result from intrinsic ability of
a given pair of complementary oligonucleotides to expand into
multiply repeated products without any template [20]. A
detailed investigation of MPR with such oligonucleotides is
described elsewhere (‘‘The Microgene Polymerization Reac-
tion’’, Itsko et al., in preparation). Essentially, the method en-
hances expansion of the duplex into DNA repeats by cycling
around its melting temperature [21]. This expansion is limited
to the duplex, whereas inserting its oligopeptide-encoded prod-
uct in frame with the gene in the vector (that needs high tem-
perature for strand separation) is accomplished by additional
standard PCR cycles, as detailed in Section 2.3. This phenom-
enon can actually be used for inserting relatively short peptide
multiple motifs in frame with a protein.
1782 M. Itsko, A. Zaritsky / FEBS Letters 581 (2007) 1775–1782The results demonstrate that the original motif of Cyt1Ca,
VIEELKSLLGINLA, exerts deleterious eﬀects on E. coli to
an extent dependent on its surrounding amino acids. The tox-
icity is possibly hidden by other parts of Cyt1Ca due to its
inherent folding. If so, nearby multiplication of this motif or
translational termination may exert its toxic action by direct
exposure or after some protease activation (Fig. 10, bottom
panel). In order to detach this region from the other parts of
Cyt1Ca and consequently prevent their interference to its anti-
bacterial activities, the protein was truncated so that a helices
C and D were at the N or C terminus (Fig. 2). The toxicity of
these variants to E. coli (Fig. 8) supports this suggestion. The
lower hydrophobicity of Cyt1Ca’s a helix C than that of
Cyt1Aa (Fig. 1) directs attention to some possible speciﬁc
rather than just hydrophobic interaction(s) between it and cell
cytoplasmic membrane, depending on speciﬁc pattern of ami-
no acid side chains.
A biological function for Cyt1Ca is still to be discovered.
The bactericidal character of the truncated versions cy-aCtr
and cy-aNtr constructed here may point to possible proteolytic
activation that it must undergo in vivo to expose its toxicity to
some yet unknown target organism. The cryptic antibacterial
action of the C-terminal domain of Cry1Ab is similarly hidden
when produced in contiguity with the N-terminal insecticidal
part of the toxin [22]. Sequestration of antibacterial activity
of Cyt1Ca in a speciﬁc fold of the whole protein may provide
a safety mechanism to protect the host bacterium.
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